His primary areas of study are Neuroscience, Alzheimer's disease, Cognition, Internal medicine and Genome-wide association study. His Neuroscience study integrates concerns from other disciplines, such as Magnetic resonance imaging and Traumatic brain injury. His Alzheimer's disease research integrates issues from Dementia, Neuroimaging and Atrophy.
His work carried out in the field of Cognition brings together such families of science as Cognitive psychology, Clinical psychology, Audiology and Cognitive decline. His Internal medicine research includes themes of Hyperintensity, Oncology and Cardiology. His research in Genome-wide association study intersects with topics in Hippocampal formation, Apolipoprotein E and Genetic association.
Andrew J. Saykin mainly investigates Disease, Neuroimaging, Neuroscience, Cognition and Internal medicine. Andrew J. Saykin has researched Disease in several fields, including Genetics and Genome-wide association study. His work deals with themes such as Alzheimer's Disease Neuroimaging Initiative, Canonical correlation, Artificial intelligence, Machine learning and Computational biology, which intersect with Neuroimaging.
The concepts of his Neuroscience study are interwoven with issues in Magnetic resonance imaging and Traumatic brain injury. Andrew J. Saykin combines subjects such as Developmental psychology, Clinical psychology, Audiology and Cognitive decline with his study of Cognition. His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology, Oncology and Cardiology.
His primary areas of investigation include Disease, Neuroimaging, Internal medicine, Cognition and Neuroscience. Andrew J. Saykin has included themes like Genetics, Computational biology and Bioinformatics in his Disease study. As a part of the same scientific study, Andrew J. Saykin usually deals with the Neuroimaging, concentrating on Neurodegeneration and frequently concerns with Amyloid.
His work investigates the relationship between Internal medicine and topics such as Oncology that intersect with problems in Alzheimer's Disease Neuroimaging Initiative. The study incorporates disciplines such as Gerontology and Audiology in addition to Cognition. His Neuroscience study frequently draws parallels with other fields, such as Disease progression.
Disease, Neuroimaging, Internal medicine, Cognitive decline and Cognition are his primary areas of study. His work deals with themes such as Precision medicine, Neuroscience and Pathogenesis, which intersect with Disease. His Neuroimaging research includes themes of Neurodegeneration, Feature selection, Canonical correlation, Artificial intelligence and Biomarker.
The study incorporates disciplines such as Endocrinology and Oncology in addition to Internal medicine. The concepts of his Cognition study are interwoven with issues in Depression, Audiology and Clinical psychology. His study looks at the intersection of Apolipoprotein E and topics like Genetic association with Genome-wide association study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang.
Nature Genetics (2011)
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
Frank Jessen;Frank Jessen;Rebecca E. Amariglio;Martin van Boxtel;Monique Breteler.
Alzheimers & Dementia (2014)
Neuropsychological Function in Schizophrenia: Selective Impairment in Memory and Learning
Andrew J. Saykin;Ruben C. Gur;Raquel E. Gur;P. David Mozley.
Archives of General Psychiatry (1991)
Neuropsychological Deficits in Neuroleptic Naive Patients With First-Episode Schizophrenia
Andrew J. Saykin;Andrew J. Saykin;Derri L. Shtasel;Raquel E. Gur;D. Brian Kester.
Archives of General Psychiatry (1994)
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
Michael W. Weiner;Michael W. Weiner;Dallas P. Veitch;Paul S. Aisen;Laurel A Beckett.
Alzheimers & Dementia (2012)
Analysis of shared heritability in common disorders of the brain
Verneri Anttila;Verneri Anttila;Brendan Bulik-Sullivan;Brendan Bulik-Sullivan;Hilary K. Finucane;Raymond K. Walters;Raymond K. Walters.
Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging : A meta-analytic study
Michael D. Nelson;Andrew J. Saykin;Andrew J. Saykin;Laura A. Flashman;Laura A. Flashman;Henry J. Riordan.
Archives of General Psychiatry (1998)
Candidate mechanisms for chemotherapy-induced cognitive changes.
Tim A. Ahles;Andrew J. Saykin;Andrew J. Saykin.
Nature Reviews Cancer (2007)
Neuropsychologic Impact of Standard-Dose Systemic Chemotherapy in Long-Term Survivors of Breast Cancer and Lymphoma
Tim A. Ahles;Andrew J. Saykin;Charlotte T. Furstenberg;Bernard Cole.
Journal of Clinical Oncology (2002)
Common genetic variants influence human subcortical brain structures.
Derrek P. Hibar;Jason L. Stein;Jason L. Stein;Miguel E. Renteria;Alejandro Arias-Vasquez.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: